daromun: Clinical Trials

2 trials of daromun, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Recruiting 1

Follow daromun: new trials by email Literature Review of daromun trials Research Report on daromun

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Daromun, Surgery, Adjuvant therapy - Melanoma Stage IIIB, Melanoma Stage IIIC
Phase 3RecruitingPhilogen S.p.A.1862018-09-202025-12-17
Neoadjuvant L19IL2/L19TNF- Pivotal Study
L19IL2 + L19TNF, Surgery - Malignant Melanoma
Phase 3Active not recruitingPhilogen S.p.A.2142016-07-012024-09-19

Conditions studied

Melanoma (2)

Sponsors

Philogen S.p.A. (2)

Countries

France (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Caroline Robert, MD (1)  ·  Mario Santinami, MD (1)  ·  Piotr Rutkowski, MD (1)

Results publications

PMID 36648215, PMID 31538818, PMID 40633690, PMID 42579833

NIH funding

2023 (1)